{"companyId":279335,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Cardiol Therapeutics Inc.","headOfficeLocation":"2265 Upper Middle Road East, Suite 602, Oakville, Ontario L6H 0G5, Canada","presidentName":"David G. Elsley","companySummary":null,"stockCode":"CRDL","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["cardiolrx.com"],"businessContents":["Clinical-stage cardiovascular therapeutics development","Anti-inflammatory drug research"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.cardiolrx.com/","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}